Sage Therapeutics, Inc.
General ticker "SAGE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $481.6M (TTM average)
Sage Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -6.0%.
Estimated limits based on current volatility of 0.9%: low 9.15$, high 9.27$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.67$, 11.14$]
- 2025-12-31 to 2026-12-31 estimated range: [5.23$, 13.69$]
Financial Metrics affecting the SAGE estimates:
- Negative: Non-GAAP EPS, $ of -6.59 <= 0.05
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -44.33 <= 1.99
- Negative: Operating profit margin, % of -91.29 <= 0.04
- Negative: Shareholder equity ratio, % of 84.99 > 63.58
- Negative: -0.32 < Industry inventory ratio change (median), % of 0
Short-term SAGE quotes
Long-term SAGE plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $7.69MM | $86.45MM | $41.24MM |
| Operating Expenses | $554.67MM | $666.30MM | $473.61MM |
| Operating Income | $-546.99MM | $-579.85MM | $-432.37MM |
| Non-Operating Income | $14.21MM | $38.36MM | $31.70MM |
| R&D Expense | $326.16MM | $356.24MM | $225.90MM |
| Income(Loss) | $-532.78MM | $-541.49MM | $-400.67MM |
| Profit(Loss)* | $-503.27MM | $-541.49MM | $-400.67MM |
| Stockholders Equity | $1,252.60MM | $799.53MM | $465.09MM |
| Inventory | $64.49MM | $0.00MM | $0.00MM |
| Assets | $1,356.45MM | $882.28MM | $547.22MM |
| Operating Cash Flow | $-460.04MM | $-540.59MM | $-267.19MM |
| Capital expenditure | $0.94MM | $0.55MM | $0.00MM |
| Investing Cash Flow | $325.43MM | $442.91MM | $266.68MM |
| Financing Cash Flow | $3.07MM | $6.03MM | $10.66MM |
| Earnings Per Share** | $-8.49 | $-9.05 | $-6.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.